Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 988 | -770 | 186 | 189 | 2,634 |
| Operating Income | -988 | 770 | -186 | -189 | -2,634 |
| Interest Expense | 1,162 | 381 | 165 | 106 | 1 |
| Other Income | 0 | -325 | 0 | 0 | 0 |
| Pre-tax Income | -2,150 | 64 | -351 | -295 | -2,635 |
| Net Income Continuous | -2,150 | 64 | -351 | -295 | -2,635 |
| Net Income | $-2,150 | $64 | $-351 | $-295 | $-2,635 |
| EPS Basic Total Ops | -3,326.17 | 13,610.76 | -603.57 | -541.67 | -17,983.33 |
| EPS Basic Continuous Ops | -3,325.05 | 13,584.81 | -606.19 | -536.48 | -17,957.30 |
| EPS Diluted Total Ops | -3,326.17 | 13,610.76 | -603.57 | -541.67 | -17,983.33 |
| EPS Diluted Continuous Ops | -3,325.05 | 13,584.81 | -606.19 | -536.48 | -17,957.30 |
| EBITDA(a) | $174 | $943 | $-140 | $-223 | $-2,599 |